Zecher Britta Franziska, Zenouzi Roman, Lang Melanie, Karagiannis Panagiotis, Clauditz Till, Fischer Lutz, Sterneck Martina, Schramm Christoph, Lohse Ansgar W, Sebode Marcial
I. Medizinische Klinik und Poliklinik, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland.
Europäisches Referenznetzwerk für seltene Lebererkrankungen (ERN RARE-LIVER), Hamburg, Deutschland.
Internist (Berl). 2021 Dec;62(12):1349-1353. doi: 10.1007/s00108-021-01148-0. Epub 2021 Sep 21.
Langerhans cell histiocytosis (LCH) is a very rare cause of secondary sclerosing cholangitis. We report the case of a 42-year-old male patient with sclerosing cholangitis and histological evidence of LCH from a bile duct biopsy. Due to rapid disease progression and exhaustion of conservative therapeutic approaches the patient received a liver transplantation. Nearly 2 years after transplantation the patient has a good graft function and no signs of recurrence of the underlying LCH.
朗格汉斯细胞组织细胞增多症(LCH)是继发性硬化性胆管炎非常罕见的病因。我们报告一例42岁男性患者,患有硬化性胆管炎,胆管活检有LCH的组织学证据。由于疾病进展迅速且保守治疗方法用尽,该患者接受了肝移植。移植后近2年,患者移植物功能良好,无潜在LCH复发迹象。